Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕Nippon India ETF Nifty Midcap 150 · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaNippon India
NAV₹29.1863₹235.6824
NAV date20 Nov 202620 Nov 2026
History5.4 years7.8 years
Expense ratio0.2%0.3%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
1 month+10.82%+5.97%
3 months+7.43%−2.55%
6 months+14.54%+1.72%
YTD+25.40%+2.66%
1 year+25.57%+2.08%
3 years (CAGR)+22.02%+13.87%
5 years (CAGR)+16.60%+14.66%
10 years (CAGR)——
Since launch+14.02%+18.99%

Risk

Nippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
Volatility15.0%18.3%
Downside volatility9.0%12.4%
Sharpe1.040.40
Sortino1.720.59
Calmar1.330.66
Return / risk1.470.76
Deepest fall−20.98%−38.35%
Days to recover136228
Below its high−1.75%−3.21%

Against benchmark

Nippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
Alpha+0.00%+0.00%
Beta1.001.00
R²100.0%100.0%
Up capture100.0%100.0%
Down capture100.0%100.0%
Tracking error0.0%0.0%
Information ratio——
Treynor0.140.06

Consistency

Nippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
Best 1-year+65.21%+116.74%
Middle 1-year+13.46%+14.06%
Worst 1-year−15.30%−33.73%
1-year periods with a loss25.8%11.6%
Middle 3-year+20.51%+24.17%
Positive months61.1%66.7%
Best day+3.64%+3.95%
Worst day−4.03%−7.10%
Worst 5% day−1.62%−2.00%
Positive days54.4%57.1%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
5-year XIRR+20.60%+14.79%
5-year value₹10,11,738₹8,75,434
3-year XIRR+19.58%+7.85%
1-year XIRR+34.31%+6.18%

Holdings overlap i

Nippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
Nippon India Nifty Pharma ETF—9%
Nippon India ETF Nifty Midcap 1509%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockNippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
Laurus Labs Limited9.26%2.41%
Lupin Limited4.83%1.25%
Aurobindo Pharma Limited4.59%1.19%
Glenmark Pharmaceuticals Limited3.42%0.89%
Alkem Laboratories Limited3.05%0.79%
Mankind Pharma Limited2.79%0.73%
IPCA Laboratories Limited2.65%0.69%
Biocon Limited2.42%0.63%
Ajanta Pharma Limited1.58%0.41%
Abbott India Limited1.32%0.34%

Sectors and company size

Nippon India Nifty Pharma ETFNippon India ETF Nifty Midcap 150
Large companies45.3%5.9%
Mid companies47.1%90.7%
Small companies7.6%2.5%
Top 10 holdings78.6%18.4%
Largest sectorPharmaceuticals & Biotechnology 100%Pharmaceuticals & Biotechnology 10%

Search Growth